CloudAlpha Capital Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-645,000
Closed -$36.5M 22
2021
Q2
$36.5M Buy
+645,000
New +$23.8M 4.39% 9
2021
Q1
Sell
-310,000
Closed -$21.7M 72
2020
Q4
$21.7M Buy
+310,000
New +$12.7M 0.44% 55

Other funds holding EDIT

CloudAlpha Capital Management's EDIT Position: Q3 2021 in Review

CloudAlpha Capital Management sold out of Editas Medicine (EDIT) in Q3 2021, closing a stake of 221,000 shares — an estimated $12.5M sold.

CloudAlpha Capital Management first reported a position in EDIT in Q4 2020 and held it in 3 quarters. The position peaked at $12.5M in Q2 2021. 318 funds tracked by Wall St. Rank hold EDIT as of Q3 2021.

  • CloudAlpha Capital Management reported no remaining Editas Medicine position as of Q3 2021 after selling out during the quarter.
  • CloudAlpha Capital Management sold 221,000 Editas Medicine shares in Q3 2021, an estimated $12.5M.
  • CloudAlpha Capital Management first reported a position in Editas Medicine in Q4 2020 and held it in 3 quarters.
  • CloudAlpha Capital Management's Editas Medicine position peaked at $12.5M in Q2 2021.
  • 318 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2021.

Based on CloudAlpha Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.